A new meta-analysis of more than 10,500 patients in the two largest randomized trials to-date testing the SENTINEL cerebral embolic protection (CEP) device as a way to protect against peri-procedural stroke during transcatheter aortic valve implantation (TAVI) confirmed there is no associated risk reduction overall for stroke.